This article covers the common symptoms of blood cancer.

It also looks at the different types and risk factors.

There are four common types of leukemia.

Acute lymphoblastic leukaemia, illustration

KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images

Types are determined based on how quickly the disease progresses, and which white blood cells are impacted.

AML

Acute myeloid leukemia (AML)is the most common form of leukemia in adults.

It is fast-growing and impacts the blood and bone marrow.

Treatment options include chemotherapy, radiation therapy, targeted therapy, or stem cell transplants.

It can spread to the liver, spleen, or lymph nodes.

It is most common in children under 15 years old or adults over 45 years old.

HCL

Hairy cell leukemia (HCL)is a rare form of CLL.

It progresses slowly and most commonly occurs in middle-aged people or older people.

HCL is a chronic disease.

CML

Just 10% of leukemias are chronic myeloid leukemia (CML).

Eventually it can spread to other parts of the body.

Between 2010 and 2016 the five-year survival rate was 63.7%.

Lymphoma

Lymphomais the result of abnormal white cells called lymphocytes multiplying rapidly and overwhelming the lymphatic system.

What’s the Difference Between Hodgkin Lymphoma and Non-Hodgkin Lymphoma ?

The main diagnostic difference between Hodgkin lymphoma and non-Hodgkin lymphoma is seen in a biopsy.

If Reed-Sternberg cells are present, then the patient has Hodgkin lymphoma.

DLBCL and follicular lymphoma are the most common types of non-Hodgkin lymphoma.

Multiple Myeloma

Multiple myelomais a cancer that begins in the plasma cells.

Plasma cells help the immune system by making antibodies to attack germs.

Symptoms are typically not seen until the cancer has advanced and spread throughout the body.

On average, every year, 1% of people with MGUS go on to develop multiple myeloma.

Smoldering myeloma is a precancerous condition where half of those diagnosed will progress to multiple myeloma within five years.

Men are more more likely to be diagnosed with multiple myeloma than women.

African-Americans are twice as likely to be diagnosed with multiple myeloma than Caucasians.

Although multiple myeloma is treatable, it is rarely curable.

The five-year survival rate for myeloma is 52%.

This can impact different types of cells, but most commonly results in a shortage of red blood cells.

There are different kinds of MDS that are categorized based on blood cells affected.

In one in three patients, MDS can progress to acute myeloid leukemia (AML).

In the past, the condition has been referred to as preleukemia.

Survival rates vary based on pop in of MDS, progression to AML, and other risk factors.

It can affect platelets, white blood cells, and red blood cells.

Types of MPD include:

Risk factors vary based on jot down of MPD.

Age, gender, and exposure to high levels of radiation, chemicals, or wiring may increase risk.

Prognosis is generally good with appropriate treatment.

The leukemic transformation in MPD differs with the throw in of MPD.

The risk at 10 years may be as high as 20% in myelofibrosis.

UMPC Hillman Cancer Center.Blood cancer symptoms and diagnosis.

UPMC Hillman Cancer Center.Leukemia.

Cancer Treatment Centers Of America.Types of leukemia.

Cancer Treatment Centers of America.Acute myeloid leukemia.

Cancer Treatment Centers of America.Acute lymphocytic leukemia.

Cancer Treatment Centers of America.Hairy cell leukemia.

Cancer Treatment Centers of America.Chronic myeloid leukemia.

Memorial Sloan Kettering Cancer Center.Risk factors for leukemia.

National Cancer Institute.Cancer stat facts: leukemia.

UPMC Hillman Cancer Center.Lymphoma.

Cancer Treatment Centers of America.What’s the difference?

Hodgkin lymphoma and non-Hodgkin lymphoma

American Cancer Society.Survival rates for Hodgkin lymphoma.

American Cancer Society.Survival rates and factors that affect prognosis (outlook) for non-Hodgkin lymphoma.

Cancer Treatment Centers of America.Multiple myeloma.

National Cancer Institute.MGUS to myeloma: Study suggests risk of progression can change.

National Cancer Institute.Drug shows promise in slowing progression of smoldering myeloma to cancer.

UPMC Hillman Cancer Center.Multiple myeloma.

American Cancer Society.Survival rates by stage for multiple myeloma.

American Cancer Society.What are myelodysplastic syndromes?

UPMC Hillman Cancer Center.MDS.

MDS Foundation.What is MDS?

UPMC Hillman Cancer Center.Myeloproliferative disorder (MPD)

UPMC Hillman Cancer Center.Myeloproliferative disorder (MPD).